Medical News

RSS

Dopamine vital for rhythmic expression in specific brain regions: Research

Daily sleeping and eating patterns are critical to human well-being and health. Now, a new study from Concordia University has demonstrated how the brain chemical dopamine regulates these cycles by altering the activity of the "clock-protein" PER2. Published in the Journal of Neuroscience, these findings may have implications for individuals with Parkinson's Disease with disrupted 24-hour rhythms of activity and sleep.

21 Oct 2010

Genzyme third quarter revenue increases to $1.0 billion

Genzyme Corp. today reported third-quarter earnings growth driven by increased shipments of Cerezyme® (imiglucerase for injection). Patients in the United States began returning to normal dosing levels last month, and patients globally are expected to be able to do so this quarter. Earnings growth in the third quarter was also driven by strong revenue from Lumizyme™ (alglucosidase alfa) and cost reduction measures.

21 Oct 2010

Beaumont Hospital announces opening of new Ernst Cardiovascular Center

Beaumont Hospitals' world renowned heart center has expanded and enhanced its services with the Oct. 18 opening of the new Ernst Cardiovascular Center at Beaumont Hospital, Royal Oak.

21 Oct 2010

Thomson Reuters introduces new version of Clinical Xpert Navigator

Thomson Reuters, a global provider of information for healthcare professionals, has released the newest version of its award-winning Clinical Xpert Navigator mobile clinical data application.

21 Oct 2010

Z-Medica enters agreement with two Swedish medical device distributors for QuikClot products

Z-Medica Corporation, a medical device company developing innovative hemostatic agents, today announced that it has signed exclusive distribution agreements with Vingmed AB and Mediplast AB, two leading Swedish medical device distributors, for distribution of its QuikClot line of hemostatic agents in Sweden, Denmark and Norway for the first time.

From Medica Corporation 21 Oct 2010

Also in Global Health News: Foreign aid in Ethiopia; Elizabeth Glaser Pediatric AIDS Foundation; Health in Myanmar; Poverty in Zambia; Rwanda's progress on MDGs; Men involved in PMTCT of HIV

Ethiopia's government has been restricting access to food and other types of foreign aid among opposition supporters, Human Rights Watch (HRW) said in a report on Tuesday, Reuters reports (Malone, 10/19). The report is based on more than 200 interviews, conducted over a six-month period in 2009, of people in 53 villages across three regions of the country, according to an HRW press release (10/19).

21 Oct 2010

Alexion announces results of eculizumab two open-label Phase 2 studies for aHUS treatment

Alexion Pharmaceuticals, Inc. today announced that its two open-label Phase 2 studies investigating eculizumab (Soliris) as a treatment for patients with atypical Hemolytic Uremic Syndrome (aHUS) have met the primary and key secondary endpoints with high clinical and statistical significance, in interim analyses.

21 Oct 2010

Genzyme reports results of Clolar combination Phase 3 trial in adult AML

Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).

21 Oct 2010

IRB approves CEL-SCI’s Multikine Phase III clinical trial for head and neck cancer

CEL-SCI Corporation announced today it has received approval from seven hospital Institutional Review Boards in India to begin enrollment of subjects for a Phase III clinical trial of Multikine, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer.

21 Oct 2010

FDA approves Herceptin with chemotherapy for HER2-positive metastatic cancer

Genentech, a member of the Roche Group today announced the U.S. Food and Drug Administration (FDA) has approved Herceptin (trastuzumab) in combination with chemotherapy (cisplatin plus either capecitabine or 5-fluorouracil [5-FU]) for HER2-positive metastatic (cancer that has spread) cancer of the stomach or gastroesophageal junction, in men and women who have not received prior medicines for their metastatic disease.

21 Oct 2010

Today's Opinions: The health law and Medicare, issues of implementation; the call for repeal

The reality is that the bill doesn't cut Medicare benefits a dime and doesn't "jeopardize access" for anybody, although it may very well force plenty of seniors to change the plans they're on. It also puts Medicare on sounder financial footing, postponing insolvency for about 12 years.

21 Oct 2010

Study: Flu vaccine is money loser for doctors paid by Medicaid

More poor children would get the flu vaccine if Medicaid increased the reimbursement to doctors for giving the shot, according to a new study published in the journal Pediatrics.

21 Oct 2010

NHS needs £20bn of efficiency savings

Britain’s NHS would become one of only two government departments not to face budget cuts in the latest spending review. However some key features have been removed. This includes one-week wait for cancer diagnosis and free prescriptions for people with long-term illnesses.

20 Oct 2010

A universal cancer treatment for a universal cancer marker

A latest study shows that a hormone receptor normally confined to the reproductive organs is found in malignant tumors in many parts of the body. Researchers from the Mt. Sinai School of Medicine in New York City explained that this may mean a new target for the early diagnosis and treatment of cancer. The study was published in the latest issue of The New England Journal of Medicine.

20 Oct 2010

Queensland Health payroll issues lead to resignation of another bureaucrat

Union representatives for Queensland Health (QH) payroll workers have backed an executive’s claims of being bullied at work. Tens of thousands of QH employees have been paid incorrectly since the payroll system was introduced in March.

20 Oct 2010

Overweight dads may pass on diabetes to their daughters: Study

According to a latest study fathers on a high-fat diet are more likely to produce daughters with a higher diabetes risk. The study was published in the journal Nature and it involved laboratory rats.

20 Oct 2010

Arena reports results of APD916 Phase 1 clinical trial for narcolepsy with cataplexy

Arena Pharmaceuticals, Inc. announced today results from a Phase 1 clinical trial of APD916, a novel drug candidate discovered by Arena that targets the histamine H3 receptor for the treatment of narcolepsy with cataplexy.

20 Oct 2010

Cipla launches generic Pirfenidone for IPF

Cipla, among the world's leading generic pharmaceutical companies, has introduced Pirfenidone in India under the brand name Pirfenex, for the treatment of IPF. A chronic progressive form of lung disease, IPF has average survival rates as low as 3-5 years which is less than many cancers. Till now there is no approved treatment for IPF.

20 Oct 2010

Health Impact Project announces $400,000 in grants to 4 organizations to conduct health impact assessments

The Health Impact Project, a collaboration of the Robert Wood Johnson Foundation and The Pew Charitable Trusts, today announced nearly $400,000 in grants to four organizations to conduct health impact assessments (HIAs). The assessments will identify and address potential and often overlooked health implications of policy proposals including farm-to-school food legislation, energy development, smart-metering technology for electric utilities and urban transportation plans.

20 Oct 2010

CASLPA celebrates International Stuttering Day on October 22

King George VI recognized the importance of speech therapy to treat his stuttering nearly 100 years ago, and it is just as important today. The Canadian Association of Speech-Language Pathologists and Audiologists celebrates the important work of speech-language pathologists to help people who stutter on International Stuttering Day October 22.

20 Oct 2010